Polysaccharide Peptide: A promising Anti Inflammation and Anti Oxidant in Atherosclerosis

Abstract

Background : Heart disease is the leading cause of death for both men and women, but heart disease is preventable and controllable. Ganoderma lucidum is widely used as traditional medicine for centuries particularly in China, Japan, and Korea. Previous study showed antioxidative activity of polysaccharide peptide (PsP) from Genoderma lucidum.
Objective : This study was aimed to evaluate anti-inflammatory and antioxidant effect of polysaccharide peptide (PsP) from Ganoderma lucidum in atherosclerotic rats.
Methods : The atherosclerotic rats were randomly divided into four groups (5 rats each group) : atherosclerotic model with high-fat diet, low dose PsP treated group (50 mg/kgBW), medium dose PsP treated group (150 mg/kgBW), high dose PsP treated group (300 mg/kgBW), with normal mice used as a control group. Parameters measured were the level of MDA, SOD, IL - 6 , IL - 10, hsCRP, TNF - ?, lipid profile and foam cell.
Results : After PsP therapy for 5 weeks, the levels of MDA (p=0.01), hsCRP (p=0.018) in rats model of atherosclerosis decrease significantly. PsSP can reduce levels of IL - 6 (p=0.933) and increase levels of SOD (p=0.28) descriptively at PsP doses 150 mg/kgBW. While the levels of TNF-? (p=0.894) and IL-10 (p=0.98) was not affected by administration of PsP. PsP improve the lipid profile by increasing HDL (p=0.002) and lowering total cholesterol (p=0.04). The formation of foam cells (p=0.024) as a marker of atherogenesis significantly decreased by administration of PsP .
Conclusion : PSP can be useful to reduce inflammatory processes and oxidative stress to prevent the process of atherogenesis.

Downloads

Download data is not yet available.

References

1. Go AS, Mozaffarian D, Roger VL, Emelia J. Benjamin, Berry JD, Blaha MJ. Heart Disease and Stroke Statistics—2014 Update. Circulation Journal. 2013;129(e28-e292).

2. Sprague A, Khalil R. Inflammatory Cytokines in Vascular Dysfunction and Vascular Disease. Biochem Pharmacol. 2009;78(6):539 - 52.

3. Yihuai G, Chen G, Xihu D, Jingxian Y, Shufeng Z. A Phase I/II Study of Ling Zhi Ganoderma lucidum (W Curt.: fr.) lloyid (Aphyllophoromycetideae) extract in patients with coronary heart disease. International Journal of Medicinal mushrooms. 2004;6:327 - 34.

4. Xu Z, Chen X, Zhong Z, Chen L, all e. Ganoderma lucidum polysaccharides : immunomodulation and potential anti-tumor activities. Am J Chin Med. 2011;39(1):15 - 27.

5. Wachtel-Galor S, Tomlinson B, Benzie IFF. Ganoderma lucidum (‘Lingzhi’), a Chinese medicinal mushroom: biomarker responses in a controlled human supplementation study. British Journal of Nutrition. 2004;91:263 - 9.

6. Zhonghui Z, Xiaowei Z, Fang F. Ganoderma lucidum polysaccharides supplementation attenuates exercise-induced oxidative stress in skeletal muscle of mice. Saudi Journal of Biological Sciences. 2013.

7. Pan D, Zhang D, Wu J, Chen C, Xu Z. Antidiabetic, Antihyperlipidemic and Antioxidant Activities of a Novel Proteoglycan from Ganoderm Lucidum Fruiting Bodies on db/db Mice and the Possible Mechanism. PLoS ONE. 2013;8(7):e68332.

8. Oluba OM, Onyeneke EC, Ojieh GC, Idonije BO, Ojiezeh TI. Hepatoprotective Potential of Aqueous Extract of Ganoderma lucidum Against Carbon Tetrachloride Intoxication in Rats. Der Pharmacia Lettre. 2010;2(4):432-9.

9. Li F, Zhang Y, Zhong Z. Antihyperglycemic Effect of Ganoderma lucidum Polysaccharides on Streptozotocin-Induced Diabetic Mice. Int J Mol Sci. 2011;12:6135-45.

10. Lin YL, Liang YC, Lee SS, Chiang BL. Polysaccharide purified from Ganoderma lucidum induced activation and maturation of human monocyte-derived dendritic cells by the NF-B and p38 mitogen-activated protein kinase pathways. Journal of Leukocyte Biology. 2005:78.

11. Sun LX. Ganoderma lucidum polysaccharides antagonize the suppression on lymphocytes induced by culture supernatants of B16F10 melanoma cells. J Pharm Pharmacol. 2011;63(5):725-35.

12. Futrakul N. Ganoderma lucidum suppresses endothelial cell cytotoxicity and proteinuria in persistent proteinuric focal segmental glomerulosclerosis (FSGS) nephrosis. Clin Hemorheol Microcirc. 2004;31(4):267-72.

13. Cui XY. Extract of Ganoderma lucidum prolongs sleep time in rats. J Ethnopharmacol. 2012;139(3):796-800.

14. Gao Y. Effects of Water-Soluble Ganoderma lucidum Polysaccharides on the Immune Functions of Patients with Advanced Lung Cancer. Journal of Medicinal Food. 2005;8(2):159-68.

15. Seto SW, Lam TY, Tam HL, Au AL, Chan SW, Wu JH, et al. Novel hypoglycemic effects of Ganoderma lucidum water-extract in obese/diabetic (+db/+db) mice. Phytomedicine : international journal of phytotherapy and phytopharmacology. 2009;16(5):426-36.

16. You YH, Lin ZB. Protective effects of Ganoderma lucidum polysaccharides peptide on injury of macrophages induced by reactive oxygen species. Acta pharmacologica Sinica. 2002;23(9):787-91.

17. Meng G, Zhu H, Yang S, Wu F, Zheng H, Chen E, et al. Attenuating effects of Ganoderma lucidum polysaccharides on myocardial collagen cross-linking relates to advanced glycation end product and antioxidant enzymes in high-fat-diet and streptozotocin-induced diabetic rats. Carbohydrate Polymers. 2011;84(1):180-5.
Published
2015-12-04
Views
Abstract views: 46   
PDF downloads: 0   
How to Cite
Polysaccharide Peptide: A promising Anti Inflammation and Anti Oxidant in Atherosclerosis. (2015). Indonesian Journal of Cardiology, 36(1), 22-7. https://doi.org/10.30701/ijc.v36i1.437
Section
Clinical Research